• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
XU Lili,TIAN Yuejie,SU Fengyun,XIE Yanjun,LI Xia.Discussion on monitoring pathway of drug induced liver injury in medical institutions[J].Journal Of Pharmaceutical Research,2022,41(8):554-556,560[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2261times   Download 2059次 QR Code for this article
Scan with your phone!
医疗机构药物性肝损伤监测路径探讨
许莉莉1,田月洁1,苏凤云2,谢彦军1,李霞1
Font:Larger+|Default|Smaller-
(1.山东省药品不良反应监测中心,山东 济南 250014;2.山东第一医科大学第二附属医院,山东 泰安 271000)
摘要:
目的 分析药物性肝损伤的发生特点和高风险因素,探讨医疗机构DILI 监测路径的建立。方法 对山东省药品不良反应监测中心数据库中2013年-2018年7月31日年5 066例和山东第一医科大学第二附属医院2016-2017年可疑DILI患者的181份的相关影响因素进行统计分析。结果 患者年龄以40-59岁患者居多;涉及药品中抗感染类药物占比最大;患者的体重、潜伏期、药品种类和原患疾病是发生严重DILI的影响因素。结论 根据药物性肝损伤发生特点和影响因素,探讨建立医疗机构药物性肝损伤的监测路径,有利于降低药物性肝损伤发生的风险。
关键词:  医疗机构  药物性肝损伤  监测路径
DOI:10.13506/j.cnki.jpr.2022.08.014
基金项目:
Publication Date:August 25, 2022
Discussion on monitoring pathway of drug induced liver injury in medical institutions
XU Lili1,TIAN Yuejie1,SU Fengyun2,XIE Yanjun1,LI Xia1
(1.Shandong Provincial Center for ADR Monitoring, Jinan 250014, China;2.The Second Affiliated Hospital of Shandong First Medical University,Taian 271000, China)
Abstract:
Objective To analyze the characteristics and high risk factors of drug-induced liver injury, and to explore the establishment of DILI monitoring path in medical institutions. Methods we statistically analyzed the related influencing factors of 5 066 suspected DILI patients from the database of ADR Monitoring Center between January 1,2013 and July 31,2018 and 181 suspected DILI patients between January 1,2016 to December 31, 2017 in the Second Affiliated Hospital of Shandong First Medical University. Results Most patients aged 40~59 years; the largest proportion of anti-infective drugs involved; the patient's weight, latency, drug type and primary disease were the influencing factors of severe DILI. Conclusion According to the characteristics and influencing factors of drug-induced liver injury, the establishment of a monitoring path for drug-induced liver injury in medical institutions is conducive to reducing the risk of drug-induced liver injury.
Key words:  Medical institutions  Drug induced liver injury  Monitoring pathway
Today's Visits:488    Total Visits:2383203
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.